Get your no-cost RSV vaccine today - CVS
The CDC recommends eligible adults receive a single dose of the RSV vaccine. Learn more about respiratory syncytial virus or schedule your appointment at CVS.
www.cvs.comI don’t have live tool access in this turn, but I can share the latest widely reported guidance on RSV vaccine eligibility up to now.
Suggested next steps to confirm eligibility in your area:
If you’d like, I can tailor this to your country (France) and provide the latest local eligibility details from public health sources.
The CDC recommends eligible adults receive a single dose of the RSV vaccine. Learn more about respiratory syncytial virus or schedule your appointment at CVS.
www.cvs.comVote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74 Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to expand its recommendation for the use of respiratory syncytial virus (RSV) vaccines approved for adults 50-59 years of age at increased risk of RSV-associated lower respiratory tract disease (LRTD). This includes...
www.pfizer.comThe CDC has published updated recommendations for older adults, detailing who should get vaccinated against RSV. The move comes after concerns were raised earlier this year that the shot may be linked to a heightened risk of a rare nervous system condition called Guillain-Barré syndrome.
www.webmd.comThe Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a vaccine against respiratory syncytial virus.
www.statnews.comFirst and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 Approval based on data from pivotal Phase 3 trial in adults at increased risk of lower respiratory tract disease caused by RSV Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tract disease (LRTD) caused...
www.pfizer.comThe CDC published a new recommendation this week calling for some adults ages 50 to 59 to get vaccinated for respiratory syncytial virus (RSV).
www.webmd.comThe Centers for Disease Control and Prevention and the Department of Health and Human Services adopted Aug. 4 the Advisory Committee on Immunization Practices’ recommendations for respiratory syncytial virus and seasonal influenza vaccinations ahead of the 2025-2026 respiratory infection season.
www.aha.orgVaccine guidance for healthcare providers for the use of RSV vaccines for adults
www.cdc.govThe respiratory illness RSV can be serious, especially in children and older adults.
www.cbsnews.com